Prophylaxis of opportunistic infections

被引:2
作者
Tantisiriwat, W [1 ]
Powderly, WG [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA
关键词
D O I
10.1016/S0891-5520(05)70140-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Opportunistic infections (OIs) are the hallmark of the immunodeficiency associated with HIV infections. In the mid-1990s, widespread use of prophylaxis strategies improved the morbidity and mortality of AIDS, and the guidelines for the prevention of most infections have been promulgated. More recently, with the introduction of potent antiretroviral therapy, there has been a dramatic change in clinical outcome of many OIs such that antiretroviral therapy should be regarded as standard treatment for any OI. In addition, the immune reconstitution that follows successful inhibition of HIV replication raises the question of withdrawal of specific antimicrobial prophylaxis. In fact, diseases that previously required lifelong maintenance therapy may be potentially curable with effective antiretroviral therapy. In this article, the authors update clinicians on the current state of the art of prophylaxis of OIs in the era of potent treatment for HIV.
引用
收藏
页码:929 / +
页数:17
相关论文
共 82 条
[1]   Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy [J].
Aberg, JA ;
Yajko, DN ;
Jacobson, MA .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) :1446-1449
[2]  
[Anonymous], 1999, MMWR Recomm Rep, V48, P1
[3]   Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS:: A randomized, double-blind, placebo-controlled trial [J].
Benson, CA ;
Williams, PL ;
Cohn, DL ;
Becker, S ;
Hojczyk, P ;
Nevin, T ;
Korvick, JA ;
Heifets, L ;
Child, CC ;
Lederman, MM ;
Reichman, RC ;
Powderly, WG ;
Notario, GF ;
Wynne, BA ;
Hafner, R .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (04) :1289-1297
[4]   A PLACEBO-CONTROLLED TRIAL OF MAINTENANCE THERAPY WITH FLUCONAZOLE AFTER TREATMENT OF CRYPTOCOCCAL MENINGITIS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BOZZETTE, SA ;
LARSEN, RA ;
CHIU, J ;
LEAL, MAE ;
JACOBSEN, J ;
ROTHMAN, P ;
ROBINSON, P ;
GILBERT, G ;
MCCUTCHAN, JA ;
TILLES, J ;
LEEDOM, JM ;
RICHMAN, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (09) :580-584
[5]   A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BOZZETTE, SA ;
FINKELSTEIN, DM ;
SPECTOR, SA ;
FRAME, P ;
POWDERLY, WG ;
HE, WL ;
PHILLIPS, L ;
CRAVEN, D ;
VANDERHORST, C ;
FEINBERG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :693-699
[6]   A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals [J].
Brosgart, CL ;
Louis, TA ;
Hillman, DW ;
Craig, CP ;
Alston, B ;
Fisher, E ;
Abrams, DI ;
Lusken-Hawk, RL ;
Sampson, JH ;
Ward, DJ ;
Thompson, MA ;
Torres, RA .
AIDS, 1998, 12 (03) :269-277
[7]   Report of the NIH Panel to Define Principles of Therapy of HIV Infection [J].
Carpenter, C ;
Feinberg, M ;
Aubry, W ;
Averitt, D ;
Coffin, J ;
Cooper, D ;
Follansbee, S ;
Hamburg, P ;
Harrington, M ;
Hidalgo, J ;
Jaffe, H ;
Landers, D ;
Masur, H ;
Pizzo, P ;
Richman, D ;
Saag, M ;
Schooley, R ;
Stone, V ;
Thompson, M ;
Trono, D ;
Vella, S ;
Walker, B ;
Yeni, P .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (12) :1057-1078
[8]   Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy [J].
Carr, A ;
Marriott, D ;
Field, A ;
Vasak, E ;
Cooper, DA .
LANCET, 1998, 351 (9098) :256-261
[9]   LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS [J].
CARR, A ;
TINDALL, B ;
BREW, BJ ;
MARRIOTT, DJ ;
HARKNESS, JL ;
PENNY, R ;
COOPER, DA .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :106-111
[10]   Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy [J].
Casado, JL ;
Arrizabalaga, J ;
Montes, M ;
Martí-Belda, P ;
Tural, C ;
Pinilla, J ;
Gutierrez, C ;
Portu, J ;
Schuurman, R ;
Aguirrebengoa, K .
AIDS, 1999, 13 (12) :1497-1502